focus -WSS

focus

author：leisure time 2025-10-01 18:23:31 - browse：388

Two researchers look at a computer monitor showing a graph and other data — Adobe

Research universities are voicing concerns over some proposed changes to the process for reviewing scientific misconduct allegations, citing worries that new government requirements would hobble their own independent procedures and constitute a huge administrative burden.

Nearly two decades since it last released research misconduct rules, the U.S. Office of Research Integrity (ORI) is ready to update its requirements for ensuring the scientific standards of projects funded by the U.S. Department of Health and Human Services, including the National Institutes of Health.

The proposed changes, published on Oct. 6, include a new formal process that institutions would follow in reviewing allegations, a 30-day deadline for institutions to assess allegations, and provisions that make it harder to quickly dismiss cases that institutions believe to be “honest errors.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Telehealth startups are trying to fill the menopause care vacuum

knowledge

WSS

Dementia risk linked to living in disadvantaged areas: Study

How a Boston hospital is priming medical residents to use GPT

Medicare isn't yet testing food as medicine

Pfizer is about to make a big push in cancer. Will investors listen?

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

knowledge

focus

entertainment

Affirmative action in medical school literally saved lives

Extensive review finds private equity owners jack up cost of care

Medical leaders decry Supreme Court decision on affirmative action

'Vaccine

In Memoriam: Notable people who died in 2023

Medicare Advantage isn’t working — for anyone

Walensky prepares to leave CDC — and Congress — behind

There’s a way to spot data fakery. All journals should be using it

Hepatitis C has a cure — but many Americans still lack access to it

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

entertainment

Using force crossed my mind when examining a defiant young patient

'CMA Fest' 2023: How to watch, who is performing and more

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

'CMA Fest' 2023: How to watch, who is performing and more

Caribou posts encouraging results on off

hotspot

knowledge

hotspot

explore